Duo Oncology

Duo Oncology is a cancer medicine company developing next-generation chemotherapy for solid tumors using ultrasmall, tumor-penetrating nanomedicines that deliver drug combinations to deep tumors. Its lead program, DUO-207, is designed to improve on existing chemotherapy approaches. The company is backed by BeOne and brings together clinical oncologists and pharmaceutical scientists.